CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 70 filers reported holding CARDIFF ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,050 | -99.9% | 750,000 | 0.0% | 0.06% | +20.4% |
| Q3 2022 | $1,155,000 | -30.0% | 750,000 | 0.0% | 0.05% | -44.3% |
| Q2 2022 | $1,650,000 | -11.3% | 750,000 | 0.0% | 0.09% | +12.8% |
| Q1 2022 | $1,860,000 | -58.7% | 750,000 | 0.0% | 0.08% | -36.1% |
| Q4 2021 | $4,508,000 | -9.7% | 750,000 | 0.0% | 0.12% | +8.9% |
| Q3 2021 | $4,995,000 | +0.1% | 750,000 | 0.0% | 0.11% | +10.9% |
| Q2 2021 | $4,988,000 | -28.2% | 750,000 | 0.0% | 0.10% | -17.9% |
| Q1 2021 | $6,945,000 | -57.1% | 750,000 | -16.7% | 0.12% | -64.7% |
| Q4 2020 | $16,191,000 | +26.8% | 900,000 | 0.0% | 0.35% | +12.3% |
| Q3 2020 | $12,771,000 | – | 900,000 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $15,158,000 | 12.39% |
| Octagon Capital Advisors LP | 982,753 | $5,906,000 | 1.15% |
| Altium Capital Management LP | 337,000 | $2,025,000 | 0.56% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $616,000 | 0.44% |
| Eventide Asset Management | 1,670,399 | $10,039,000 | 0.13% |
| Artal Group S.A. | 750,000 | $4,508,000 | 0.12% |
| Aquatic Capital Management LLC | 8,000 | $48,000 | 0.09% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 17,300 | $104,000 | 0.06% |
| Anson Funds Management LP | 69,381 | $417,000 | 0.04% |
| KENNEDY CAPITAL MANAGEMENT LLC | 170,447 | $1,024,000 | 0.02% |